Literature DB >> 22231195

Dementia in 2011: Microbleeds in dementia--singing a different ARIA.

Philip Scheltens1, Jeroen D C Goos.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22231195     DOI： 10.1038/nrneurol.2011.222

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  8 in total

1.  Comparison of 7.0-T T₂*-magnetic resonance imaging of cerebral bleeds in post-mortem brain sections of Alzheimer patients with their neuropathological correlates.

Authors:  J De Reuck; F Auger; C Cordonnier; V Deramecourt; N Durieux; F Pasquier; R Bordet; C A Maurage; D Leys
Journal:  Cerebrovasc Dis       Date:  2011-03-21       Impact factor: 2.762

Review 2.  Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup.

Authors:  Reisa A Sperling; Clifford R Jack; Sandra E Black; Matthew P Frosch; Steven M Greenberg; Bradley T Hyman; Philip Scheltens; Maria C Carrillo; William Thies; Martin M Bednar; Ronald S Black; H Robert Brashear; Michael Grundman; Eric R Siemers; Howard H Feldman; Rachel J Schindler
Journal:  Alzheimers Dement       Date:  2011-07       Impact factor: 21.566

3.  Clinical relevance of improved microbleed detection by susceptibility-weighted magnetic resonance imaging.

Authors:  Jeroen D C Goos; Wiesje M van der Flier; Dirk L Knol; Petra J W Pouwels; Philip Scheltens; Frederik Barkhof; Mike P Wattjes
Journal:  Stroke       Date:  2011-05-12       Impact factor: 7.914

Review 4.  Brain microbleeds and Alzheimer's disease: innocent observation or key player?

Authors:  Charlotte Cordonnier; Wiesje M van der Flier
Journal:  Brain       Date:  2011-01-21       Impact factor: 13.501

5.  Cerebral microhemorrhage and brain β-amyloid in aging and Alzheimer disease.

Authors:  P A Yates; R Sirisriro; V L Villemagne; S Farquharson; C L Masters; C C Rowe
Journal:  Neurology       Date:  2011-06-22       Impact factor: 9.910

6.  Microbleeds relate to altered amyloid-β metabolism in Alzheimer's disease.

Authors:  Jeroen D C Goos; Charlotte E Teunissen; Robert Veerhuis; Nicolaas A Verwey; Frederik Barkhof; Marinus A Blankenstein; Philip Scheltens; Wiesje M van der Flier
Journal:  Neurobiol Aging       Date:  2011-11-26       Impact factor: 4.673

7.  Cerebral microbleeds are predictive of mortality in the elderly.

Authors:  Irmhild Altmann-Schneider; Stella Trompet; Anton J M de Craen; Adriaan C G M van Es; J Wouter Jukema; David J Stott; Naveed Sattar; Rudi G J Westendorp; Mark A van Buchem; Jeroen van der Grond
Journal:  Stroke       Date:  2011-01-13       Impact factor: 7.914

8.  MRI biomarkers of vascular damage and atrophy predicting mortality in a memory clinic population.

Authors:  Wouter J P Henneman; Jasper D Sluimer; Charlotte Cordonnier; Merel M E Baak; Philip Scheltens; Frederik Barkhof; Wiesje M van der Flier
Journal:  Stroke       Date:  2008-12-24       Impact factor: 7.914
  8 in total
  3 in total

1.  Cerebral microbleeds in a multiethnic elderly community: demographic and clinical correlates.

Authors:  Anne F Wiegman; Irene B Meier; Nicole Schupf; Jennifer J Manly; Vanessa A Guzman; Atul Narkhede; Yaakov Stern; Sergi Martinez-Ramirez; Anand Viswanathan; José A Luchsinger; Steven M Greenberg; Richard Mayeux; Adam M Brickman
Journal:  J Neurol Sci       Date:  2014-07-18       Impact factor: 3.181

2.  Reconstruction of the human blood-brain barrier in vitro reveals a pathogenic mechanism of APOE4 in pericytes.

Authors:  Joel W Blanchard; Michael Bula; Jose Davila-Velderrain; Leyla Anne Akay; Lena Zhu; Alexander Frank; Matheus B Victor; Julia Maeve Bonner; Hansruedi Mathys; Yuan-Ta Lin; Tak Ko; David A Bennett; Hugh P Cam; Manolis Kellis; Li-Huei Tsai
Journal:  Nat Med       Date:  2020-06-08       Impact factor: 53.440

Review 3.  Fibrinogen in neurological diseases: mechanisms, imaging and therapeutics.

Authors:  Mark A Petersen; Jae Kyu Ryu; Katerina Akassoglou
Journal:  Nat Rev Neurosci       Date:  2018-04-05       Impact factor: 34.870
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.